DISCOUNT ZERTIFIKAT - KENVUE Share Price

Certificat

DE000ME8KV05

Market Closed - Börse Stuttgart 16:52:29 28/06/2024 BST
12.92 EUR -0.08% Intraday chart for DISCOUNT ZERTIFIKAT - KENVUE
1 month+2.46%
3 months+1.81%
Date Price Change
28/06/24 12.92 -0.08%
27/06/24 12.93 -0.31%
26/06/24 12.97 +0.31%
25/06/24 12.93 +0.15%
24/06/24 12.91 -0.08%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 04:52 pm

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying KENVUE INC.
Issuer Morgan Stanley
WKN ME8KV0
ISINDE000ME8KV05
Date issued 12/02/2024
Cap 14 $
Last trading day 20/09/2024
Maturity 20/09/2024 (84 Days)
Parity 1 : 1
Emission price 12.71
Emission volume N/A
Payment day 27/09/2024
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 0.000000 %
Sideways yield 0.000000 %
Sideways yield pa 0.000000 %
Outperformance point- $
Break even 0.000000 €
Highest since issue 12.97
Lowest since issue 12.39
Distance Cap 4.18 $
Distance Cap %+22.99%
Max. earning-
Max. earning % 0.000000 %

Company Profile

Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. The business is organized around 3 product families: - health products: for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - body care products: hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.); - other: notably oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.). Product marketing is assured through direct sales, distributors and the Internet.
Sector
-
More about the company

Ratings for Kenvue Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Kenvue Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
18.18 USD
Average target price
22.54 USD
Spread / Average Target
+23.97%
Consensus